Comparison of pulsed actinomycin D versus 5‐day methotrexate for the treatment of low‐risk gestational trophoblastic disease
Azamsadat Mousavi(Tehran University of Medical Sciences), Hadi Shojaei(Cooper University Health Care), Fariba Yarandi(University of Tehran), Mitra Modaress Gilani(Tehran University of Medical Sciences), Fatemeh Cheraghi(Tehran University of Medical Sciences)
Cited by 51
Related Papers
MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
|Molecular Cancer|2014|559
Pulse methotrexate versus pulse actinomycin D in the treatment of low‐risk gestational trophoblastic neoplasia
|International Journal of Gynecology & Obstetrics|2008|68
Efficacy of Megestrol Acetate (Megace) in the Treatment of Patients With Early Endometrial Adenocarcinoma: Our Experiences With 21 Patients
|International Journal of Gynecological Cancer|2009|65
Chronic Pain after Spinal Cord Injury: Results of a Long-Term Study
|Pain Medicine|2010|56